Evidence Based Medicine
In the past, treating patients with spinal disease has been difficult because of the lack of meaningful, individualized test results. New molecular tests like ScoliScore™ AIS Prognostic Test, allow you to personalize your professional treatment recommendations. In turn, individualized recommendations bring greater comfort and peace of mind to your patients, the potential for improved treatment options, and overall improved outcomes.
In the fight against spinal diseases we have a lot in common. Like you, we are clinicians and researchers who share a deep-seated belief in our lives' work, and in its potential to touch the lives of patients. We invite you to participate in our quest for improved treatment options for patients with spinal diseases by forwarding your input, feedback and suggestions. We believe that this collaboration is invaluable.
